BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3003939)

  • 1. [Anti-HTLV-III in hemophilic patients in Barcelona].
    Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J
    Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939
    [No Abstract]   [Full Text] [Related]  

  • 2. [The occurrence of LAV/HTLV III antibodies in patients with hemophilia in the County of Funen].
    Larsen FS; Høst A; Munk-Andersen G
    Ugeskr Laeger; 1986 Mar; 148(14):865-7. PubMed ID: 3010526
    [No Abstract]   [Full Text] [Related]  

  • 3. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS.
    Chorba TL; Jason JM; Ramsey RB; Lechner K; Pabinger-Fasching I; Kalyanaraman VS; McDougal JS; Cabradilla CD; Tregillus LC; Lawrence DN
    Thromb Haemost; 1985 Apr; 53(2):180-2. PubMed ID: 2992112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
    Allain JP
    N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
    [No Abstract]   [Full Text] [Related]  

  • 5. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 6. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
    Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX
    Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anal intercourse as a possible factor in heterosexual transmission of HTLV-III to spouses of hemophiliacs.
    Melbye M; Ingerslev J; Biggar RJ; Alexander S; Sarin PS; Goedert JJ; Zachariae E; Ebbesen P; Stenbjerg S
    N Engl J Med; 1985 Mar; 312(13):857. PubMed ID: 2983213
    [No Abstract]   [Full Text] [Related]  

  • 8. HTLV-III, haemophilia, and blood transfusion.
    Bloom AL; Forbes CD; Rizza CR
    Br Med J (Clin Res Ed); 1985 Jun; 290(6485):1901-2. PubMed ID: 2988692
    [No Abstract]   [Full Text] [Related]  

  • 9. HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain.
    Tor J; Muga R; Argelagues E; Rey-Joly C; Foz M; Ribas-Mundó M
    Arch Intern Med; 1986 Apr; 146(4):805. PubMed ID: 3008680
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of HTLV-III antibodies and cellular immune status of hemophiliacs.
    Tsoukas C; Gervais F; Shuster J; Gold P; O'Shaughnessy M; Robert-Guroff M
    N Engl J Med; 1984 Dec; 311(23):1514-5. PubMed ID: 6095077
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of antibodies to human T-lymphotropic viruses type I and III in Japanese hemophiliacs.
    Koyanagi Y; Kobayashi S; Harada S; Kikukawa R; Yamamoto N; Watanabe K; Okino F; Kajii T
    AIDS Res; 1983-1984; 1(5):353-8. PubMed ID: 6100780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to the human T-cell lymphoma/leukemia virus type I in Dutch haemophiliacs.
    Goudsmit J; Miedema F; Breederveld C; Terpstra F; Roos M; Schellekens P; Melief C
    Vox Sang; 1986; 50(1):12-5. PubMed ID: 3006351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to human T-cell leukemia virus type III in hemophiliacs from Spain.
    Kitchen L; Leal M; Wichmann I; Lissen E; Ollero M; Allan JS; McLane MF; Essex M
    Blood; 1985 Dec; 66(6):1473-5. PubMed ID: 2998515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies].
    Aymard JP; Janot C; Briquel ME; André E; Schooneman F; Vigneron C; Legras B; Alexandre P; Streiff F
    Pathol Biol (Paris); 1985 Dec; 33(10):951-6. PubMed ID: 3005949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroconversion for HTLV-III since 1980 in British haemophiliacs.
    Machin SJ; McVerry BA; Cheingsong-Popov R; Tedder RS
    Lancet; 1985 Feb; 1(8424):336. PubMed ID: 2857382
    [No Abstract]   [Full Text] [Related]  

  • 16. Seroepidemiologic screening for antibodies to LAV/HTLV-III in Sri Lanka, 1980-1982.
    Miller RA; Collier AC; Buchanan TM; Handsfield HH
    N Engl J Med; 1985 Nov; 313(21):1352-3. PubMed ID: 2997608
    [No Abstract]   [Full Text] [Related]  

  • 17. The prevalence of HTLV-III and HTLV-I antibodies in serum of hemophiliacs.
    De Rossi A; Dalla Gassa O; Chieco Bianchi L; Dal Bo Zanon R; Boscaro M; Girolami A
    Thromb Haemost; 1985 Dec; 54(4):897. PubMed ID: 3003957
    [No Abstract]   [Full Text] [Related]  

  • 18. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A.
    Shannon BT; Roach J; Cheek-Luten M; Ruymann FB
    Diagn Immunol; 1986; 4(1):37-42. PubMed ID: 3006971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adult T cell leukemia associated with antigen-positive cases due to blood transfusion].
    Hitomi Y; Ooto S; Watanabe Y; Tohyama H; Yokota S
    Rinsho Ketsueki; 1987 Oct; 28(10):1881-6. PubMed ID: 2898544
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preventive measures against HTLV-III/LAV infections among hemophiliacs and their relatives].
    Evensen SA; Frøland SS; Glomstein A
    Tidsskr Nor Laegeforen; 1986 Jan; 106(1):19-21. PubMed ID: 3006278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.